Effect of propylthiouracil on the ethanol‐induced increase in liver oxygen consumption in awake rats

Frederick J. Carmichael, Hector Orrego, Victor Saldivia, Yedy Israel – 1 August 1993 – It has been postulated that the beneficial effects of the antithyroid drug propylthiouracil in the treatment of alcoholic liver disease depend primarily on the action of propylthiouracil in suppressing the increase in hepatic oxygen consumption induced by ethanol. The evidence for this effect of propylthiouracil is derived from studies in which liver oxygen consumption has been determined in in vitro preparations.

Impaired responsiveness to angiotensin II in experimental cirrhosis: Role of nitric oxide

Anna Castro, Wladimiro Jiménez, Joan Clária, Josefa Ros, Josep Maria Martínez, Marta Bosch, Vicente Arroyo, Jaume Piulats, Francisca River, Joan Rodés – 1 August 1993 – Impaired vascular responsiveness to angiotensin II is a common feature in human cirrhosis with ascites. The aim of this study was to investigate whether vascular reactivity to angiotensin II is also decreased in rats with carbon tetrachloride–induced cirrhosis and ascites and to assess the role of endogenous nitric oxide in this abnormality.

Glucose resistance contributes to diabetes mellitus in cirrhosis

Alexander S. Petrides, Dirk Schulze‐Berge, Christoph Vogt, Dwight E. Matthews, Georg Strohmeye – 1 August 1993 – Insulin resistance is a characteristic feature of glucose‐intolerant and diabetic cirrhotic patients. The pathogenic factors, however, that are responsible for the development of impaired glucose tolerance in cirrhosis, remain unclear.

Mechanism of ionomycin‐induced intracellular alkalinization of rat hepatocytes

M. Sawkat Anwer – 1 August 1993 – Calcium ionophores such as ionomycin and A23187 are often used to determine the role of intracellular Ca+ + in cellular processes. Ionomycin but not Ca+ +‐mobilizing agonists increases basal intracellular pH in hepatocytes. To explain this difference in effects of agents that increase intracellular Ca+ + concentration, the mechanism of ionomycin‐induced increases in basal intracellular pH in isolated rat hepatocytes was studied.

Hepatocyte‐specific expression of the mouse hepatocyte growth factor–like protein

Jorge A. Bezerra, David P. Witte, Bruce J. Arono, Sandra J. Friezner – 1 August 1993 – We have cloned and characterized the gene and complementary DNA for a new kringle‐containing protein. Although the function of this protein is not known, it has been called hepatocyte growth factor–like protein because it shares the same structural domains as hepatocyte growth factor, with four kringle structures followed by a region homologous to serine proteases.

Interferon‐γ inhibits liver regeneration by stimulating major histocompatibility complex class II antigen expression by regenerating liver

Yoshinobu Sato, Kazuhiro Tsukada, Yoh Matsumot, Toru Ab – 1 August 1993 – The effects of interferon‐γ and interleukin‐2 on liver regeneration after 70% hepatectomy in rats was studied immunohistologically, with special attention paid to major histocompatibility complex class II antigen expression. Liver regeneration 2 days after partial hepatectomy as assessed on the basis of bromodeoxyuridine labeling index revealed that regeneration was inhibited significantly in rats given a single dose of interleukin‐2 or interferon‐γ compared with rats that underwent only partial hepatectomy.

Partial splenic embolization for the treatment of hypersplenism in cirrhosis

Bruno Sangro, Ignacio Bilbao, Ignacio Herrero, Carmen Corella, Jesus Longo, Oscar Beloqui, Juan Ruiz, Jose M. Zozaya, Jorge Quirog, Jesus Priet – 1 August 1993 – Hypersplenism is of great relevance in the management of cirrhosis because of the widespread use of myelodepressant drugs such as interferon or antineoplastic agents. Because no standard therapy exists for this complication, we have evaluated the efficacy and risks of splenic embolization in the treatment of hypersplenism in cirrhosis.

Subscribe to